Paul Noel Brennan (Paul N Brennan, P Brennan, Paul Brennan, P N Brennan)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 26

Top Venues

BMJ open gastroenterology

PloS one

Alimentary pharmacology & therapeutics

Liver international : official journal of the International Association for the Study of the Liver

University of Dundee

Dublin City University (BSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Dundee

United Kingdom

SCREDs Clinical Lecturer in Hepatology and Gastroenterology :: School of Medicine

Education History

Dublin City University Aug 01 2002 - Jul 01 2006

Ireland

BSC

Publications

Christopher J Byrne, Paul Noel Brennan, James Carberry, James Cotton, John F Dillon
Long-term risk factors for developing Barrett's oesophagus in patients with gastro-oesophageal reflux disease: a longitudinal cohort study. BMJ open gastroenterology 11 (1) (2024)
Jeffrey Victor Lazarus, Dana Ivancovsky Wajcman, Henry E Mark, Zobair M Younossi, Christopher J Kopka, Nevin Cohen, Meena B Bansal, Michael Betel, Paul Noel Brennan
Opportunities and challenges following approval of resmetirom for MASH liver disease. Nature medicine (2024)
Marc Gurun, Paul Noel Brennan, Sava Handjiev, Aseil Khatib, Damien Leith, John F Dillon, Christopher J Byrne
Increased risk of chronic kidney disease and mortality in a cohort of people diagnosed with metabolic dysfunction associated steatotic liver disease with hepatic fibrosis. PloS one 19 (4) (2024)
Christopher J Byrne, Paul Noel Brennan, James Carberry, James Cotton, John F Dillon
Long-term risk factors for developing Barrett's oesophagus in patients with gastro-oesophageal reflux disease: a longitudinal cohort study. BMJ open gastroenterology 11 (1) (2024)
Marc Gurun, Paul Noel Brennan, Sava Handjiev, Aseil Khatib, Damien Leith, John F Dillon, Christopher J Byrne
Increased risk of chronic kidney disease and mortality in a cohort of people diagnosed with metabolic dysfunction associated steatotic liver disease with hepatic fibrosis. PloS one 19 (4) (2024)
Christopher J Kopka, Nicola Pugliese, Paul Noel Brennan, Jeffrey Victor Lazarus
We must address the MASLD awareness gap, improve educational quality and prepare for the digitally quantified self. Liver international : official journal of the International Association for the Study of the Liver 44 (9) (2024)
Marc Gurun, Paul Noel Brennan, Sava Handjiev, Aseil Khatib, Damien Leith, John F Dillon, Christopher J Byrne
Increased risk of chronic kidney disease and mortality in a cohort of people diagnosed with metabolic dysfunction associated steatotic liver disease with hepatic fibrosis. PloS one 19 (4) (2024)
Marc Gurun, Paul Noel Brennan, Sava Handjiev, Aseil Khatib, Damien Leith, John F Dillon, Christopher J Byrne
Increased risk of chronic kidney disease and mortality in a cohort of people diagnosed with metabolic dysfunction associated steatotic liver disease with hepatic fibrosis. PloS one 19 (4) (2024)
Christopher J Byrne, Paul Noel Brennan, James Carberry, James Cotton, John F Dillon
Long-term risk factors for developing Barrett's oesophagus in patients with gastro-oesophageal reflux disease: a longitudinal cohort study. BMJ open gastroenterology 11 (1) (2024)
Christopher J Byrne, Paul Noel Brennan, James Carberry, James Cotton, John F Dillon
Long-term risk factors for developing Barrett's oesophagus in patients with gastro-oesophageal reflux disease: a longitudinal cohort study. BMJ open gastroenterology 11 (1) (2024)
Dana Ivancovsky-Wajcman, Paul Noel Brennan, Christopher J Kopka, Shira Zelber-Sagi, Zobair M Younossi, Alina M Allen, Karen R Flórez, Jeffrey Victor Lazarus
Integrating social nutrition principles into the treatment of steatotic liver disease. Communications medicine 3 (1) (2023)
Paul Noel Brennan, Ahmed M Elsharkawy, Timothy James Kendall, Rohit Loomba, Derek A Mann, Jonathan Andrew Fallowfield
Antifibrotic therapy in nonalcoholic steatohepatitis: time for a human-centric approach. Nature reviews. Gastroenterology & hepatology (2023)
Paul Noel Brennan, Christopher J Byrne, John F Dillon
Decentralisation of hepatitis C virus care into community settings: A key approach on the path to elimination. Liver international : official journal of the International Association for the Study of the Liver 42 (6) (2022)
Thomas Manship, Paul Noel Brennan, Iona Campbell, Stewart Campbell, Thomas Clouston, John F Dillon, Ewan Forrest, Andrew Fraser, Tee Lin Goh, Michael Johnston, Muhammad I Khan, Victoria Livie, Iain Alexander Murray, Jayne Saunders, Debbie Troland, Ken J Simpson
Effect of COVID-19 on presentations of decompensated liver disease in Scotland. BMJ open gastroenterology 9 (1) (2022)
Chan Keat Kang, Paul Noel Brennan, John F Dillon
How to Effectively Monitor Aging Patients with Chronic Hepatitis B: A Review. Clinical interventions in aging 17 (2022)
Kathleen Clare, John F Dillon, Paul Noel Brennan
Reactive Oxygen Species and Oxidative Stress in the Pathogenesis of MAFLD. Journal of clinical and translational hepatology 10 (5) (2022)
Chan Keat Kang, Paul Noel Brennan, John F Dillon
How to Effectively Monitor Aging Patients with Chronic Hepatitis B: A Review. Clinical interventions in aging 17 (2022)
Chan Keat Kang, Paul Noel Brennan, John F Dillon
How to Effectively Monitor Aging Patients with Chronic Hepatitis B: A Review. Clinical interventions in aging 17 (2022)
Paul Noel Brennan, Peter Cartlidge, Thomas Manship, John F Dillon
Guideline review: EASL clinical practice guidelines: drug-induced liver injury (DILI). Frontline gastroenterology 13 (4) (2021)
Paul Noel Brennan, Mark MacMillan, Thomas Manship, Francesca Moroni, Alison Glover, Catriona Graham, Scott Semple, David M Morris, Alasdair R Fraser, Chloe Pass, Neil W A McGowan, Marc L Turner, Neil Lachlan, John F Dillon, John D M Campbell, Jonathan Andrew Fallowfield, Stuart J Forbes
Study protocol: a multicentre, open-label, parallel-group, phase 2, randomised controlled trial of autologous macrophage therapy for liver cirrhosis (MATCH). BMJ open 11 (11) (2021)
Paul Noel Brennan, John F Dillon, Elliot B Tapper
Gamma-Glutamyl Transferase (γ-GT) - an old dog with new tricks? Liver international : official journal of the International Association for the Study of the Liver (2021)
Heather Walker, Paul Noel Brennan, Maximillian Groome, Shaun Walsh, Frank Carey
Nivolumab and immune-mediated colitis. Clinical case reports 7 (4) (2019)
Paul Noel Brennan, J F Dillon
Editorial: there is trouble ahead, but just how much? The troubling reality of America's excesses and NAFLD. Alimentary pharmacology & therapeutics 47 (2) (2019)
Paul Noel Brennan, Mhairi Claire Donnelly, Kenneth J Simpson
Letter: acute liver failure of indeterminate aetiology-Authors' reply. Alimentary pharmacology & therapeutics 48 (9) (2019)
Paul Noel Brennan, Mhairi Claire Donnelly, K J Simpson
Systematic review: non A-E, seronegative or indeterminate hepatitis; what is this deadly disease? Alimentary pharmacology & therapeutics 47 (8) (2018)
Paul Noel Brennan, A Bathgate
Editorial: is surveillance for hepatocellular carcinoma really required for all British cirrhotics? Alimentary pharmacology & therapeutics 45 (9) (2017)

Paul Noel Brennan.css-eqlu8i{font-size:small;padding-left:4px;} (Paul N Brennan, P Brennan, Paul Brennan, P N Brennan)

Publication Activity (10 Years)

Top Topics

Top Venues

Paul Noel Brennan (Paul N Brennan, P Brennan, Paul Brennan, P N Brennan)